1 2156 99 THE EFFECTS OF THE BALI YOGA PROGRAM FOR BREAST CANCER PATIENTS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: RESULTS OF A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL. COMPLEMENTARY AND ALTERNATIVE MEDICINE HAS BEEN SHOWN TO BE BENEFICIAL IN REDUCING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING. HOWEVER, CONCLUSIVE RESULTS ARE LACKING IN ORDER TO CONFIRM ITS USEFULNESS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE WHETHER A STANDARDIZED YOGA INTERVENTION COULD REDUCE THESE ADVERSE SYMPTOMS. THIS WAS A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL COMPARING A STANDARDIZED YOGA INTERVENTION WITH STANDARD CARE. ELIGIBLE PATIENTS WERE ADULTS DIAGNOSED WITH STAGES I TO III BREAST CANCER RECEIVING CHEMOTHERAPY. PATIENTS RANDOMIZED TO THE EXPERIMENTAL GROUP PARTICIPATED IN AN 8-WEEK YOGA PROGRAM. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE EXPERIMENTAL AND CONTROL GROUPS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING AFTER 8 WEEKS. RESULTS SUGGEST THE YOGA PROGRAM IS NOT BENEFICIAL IN MANAGING THESE ADVERSE SYMPTOMS. HOWEVER, CONSIDERING PRELIMINARY EVIDENCE SUGGESTING YOGA'S BENEFICIAL IMPACT IN CANCER SYMPTOM MANAGEMENT, METHODOLOGICAL LIMITATIONS SHOULD BE EXPLORED AND ADDITIONAL STUDIES SHOULD BE CONDUCTED. 2017 2 1556 35 LONG-TERM CHANGES OF SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE IN CANCER PATIENTS 6 MONTHS AFTER THE END OF YOGA THERAPY. BACKGROUND: SYMPTOMS OF ANXIETY, DEPRESSION, AND CANCER-RELATED FATIGUE ARE COMMONLY ASSOCIATED WITH CANCER. CANCER PATIENTS INCREASINGLY USE COMPLEMENTARY AND ALTERNATIVE TREATMENTS, SUCH AS YOGA, TO COPE WITH PSYCHOLOGICAL AND PHYSICAL IMPAIRMENTS. IN THE PRESENT ARTICLE, LONG-TERM CHANGES OF ANXIETY, DEPRESSION, AND FATIGUE IN CANCER ARE EXAMINED 6 MONTHS AFTER A YOGA INTERVENTION. METHOD: WE USED AN OBSERVATIONAL DESIGN BASED ON A RANDOMIZED CONTROLLED STUDY IN CANCER PATIENTS WITH MIXED DIAGNOSES TO EVALUATE LONG-TERM CHANGES OF SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE 6 MONTHS AFTER THE END OF YOGA THERAPY. WE MEASURED ANXIETY SYMPTOMS WITH THE GENERALIZED ANXIETY DISORDER SCALE (GAD-7), DEPRESSIVE SYMPTOMS WITH THE PATIENT HEALTH QUESTIONNAIRE-2 (PHQ-2), AND FATIGUE WITH THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE-FATIGUE SCALE (EORTC QLQ-FA13). YOGA THERAPY WAS PROVIDED IN YOGA CLASSES OF 60 MINUTES EACH ONCE A WEEK FOR 8 WEEKS IN TOTAL. THE EXERCISES PROVIDED CONTAINED BOTH BODY AND BREATHING ACTIVITIES AS WELL AS MEDITATION. RESULTS: A TOTAL OF 58 PATIENTS PARTICIPATED IN THE STUDY. SIX MONTHS AFTER THE END OF YOGA THERAPY, SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE WERE SIGNIFICANTLY REDUCED COMPARED WITH BASELINE. HOWEVER, SYMPTOMS OF ANXIETY AND FATIGUE SLIGHTLY INCREASED DURING THE FOLLOW-UP PERIOD, WHEREAS SYMPTOMS OF DEPRESSION REMAINED STABLE. CONCLUSION: OUR RESULTS ARE PROMISING AND SUPPORT THE INTEGRATION OF YOGA INTERVENTIONS IN SUPPORTIVE CANCER TREATMENT CONCEPTS BUT SHOULD BE CONFIRMED BY RANDOMIZED CONTROLLED TRIALS. LONG-TERM EFFECTS OF YOGA THERAPY ON CANCER PATIENTS SHOULD BE THE SUBJECT OF FURTHER RESEARCH. 2019 3 2508 45 YOGA BREATHING FOR CANCER CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE: RESULTS OF A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: MANY DEBILITATING SYMPTOMS ARISE FROM CANCER AND ITS TREATMENT THAT ARE OFTEN UNRELIEVED BY ESTABLISHED METHODS. PRANAYAMA, A SERIES OF YOGIC BREATHING TECHNIQUES, MAY IMPROVE CANCER-RELATED SYMPTOMS AND QUALITY OF LIFE, BUT IT HAS NOT BEEN STUDIED FOR THIS PURPOSE. OBJECTIVES: A PILOT STUDY WAS PERFORMED TO EVALUATE FEASIBILITY AND TO TEST THE EFFECTS OF PRANAYAMA ON CANCER-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. DESIGN: THIS WAS A RANDOMIZED CONTROLLED CLINICAL TRIAL COMPARING PRANAYAMA TO USUAL CARE. SETTING: THE STUDY WAS CONDUCTED AT A UNIVERSITY MEDICAL CENTER. SUBJECTS: PATIENTS RECEIVING CANCER CHEMOTHERAPY WERE RANDOMIZED TO RECEIVE PRANAYAMA IMMEDIATELY OR AFTER A WAITING PERIOD (CONTROL GROUP). INTERVENTIONS: THE PRANAYAMA INTERVENTION CONSISTED OF FOUR BREATHING TECHNIQUES TAUGHT IN WEEKLY CLASSES AND PRACTICED AT HOME. THE TREATMENT GROUP RECEIVED PRANAYAMA DURING TWO CONSECUTIVE CYCLES OF CHEMOTHERAPY. THE CONTROL GROUP RECEIVED USUAL CARE DURING THEIR FIRST CYCLE, AND RECEIVED PRANAYAMA DURING THEIR SECOND CYCLE OF CHEMOTHERAPY. OUTCOME MEASURES: FEASIBILITY, CANCER-ASSOCIATED SYMPTOMS (FATIGUE, SLEEP DISTURBANCE, ANXIETY, DEPRESSION, STRESS), AND QUALITY OF LIFE WERE THE OUTCOMES. RESULTS: CLASS ATTENDANCE WAS NEARLY 100% IN BOTH GROUPS. SIXTEEN (16) PARTICIPANTS WERE INCLUDED IN THE FINAL INTENT-TO-TREAT ANALYSES. THE REPEATED-MEASURES ANALYSES DEMONSTRATED THAT ANY INCREASE IN PRANAYAMA DOSE, WITH DOSE MEASURED IN THE NUMBER OF HOURS PRACTICED IN CLASS OR AT HOME, RESULTED IN IMPROVED SYMPTOM AND QUALITY-OF-LIFE SCORES. SEVERAL OF THESE ASSOCIATIONS--SLEEP DISTURBANCE (P=0.04), ANXIETY (P=0.04), AND MENTAL QUALITY OF LIFE (P=0.05)--REACHED OR APPROACHED STATISTICAL SIGNIFICANCE. CONCLUSIONS: YOGA BREATHING WAS A FEASIBLE INTERVENTION AMONG PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY. PRANAYAMA MAY IMPROVE SLEEP DISTURBANCE, ANXIETY, AND MENTAL QUALITY OF LIFE. A DOSE-RESPONSE RELATIONSHIP WAS FOUND BETWEEN PRANAYAMA USE AND IMPROVEMENTS IN CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. THESE FINDINGS NEED TO BE CONFIRMED IN A LARGER STUDY. 2012 4 428 36 CAN YOGA HAVE ANY EFFECT ON SHOULDER AND ARM PAIN AND QUALITY OF LIFE IN PATIENTS WITH BREAST CANCER? A RANDOMIZED, CONTROLLED, SINGLE-BLIND TRIAL. OBJECTIVE: TO EXAMINE THE EFFECTS OF YOGA ON SHOULDER AND ARM PAIN, QUALITY OF LIFE (QOL), DEPRESSION, AND PHYSICAL PERFORMANCE IN PATIENTS WITH BREAST CANCER. METHODS: THIS PROSPECTIVE, RANDOMIZED STUDY INCLUDED 42 PATIENTS. THE PATIENTS IN GROUP 1 UNDERWENT A 10-WEEK HATHA YOGA EXERCISE PROGRAM. THE PATIENTS IN GROUP 2 WERE INCLUDED IN A 10-WEEK FOLLOW-UP PROGRAM. OUR PRIMARY ENDPOINT WAS ARM AND SHOULDER PAIN INTENSITY. RESULTS: THE GROUP RECEIVING YOGA SHOWED A SIGNIFICANT IMPROVEMENT IN THEIR PAIN SEVERITY FROM BASELINE TO POST-TREATMENT, AND THESE BENEFITS WERE MAINTAINED AT 2.5 MONTHS POST-TREATMENT. WHEN COMPARED TO THE CONTROL GROUP, THERE WERE NO STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE 2 GROUPS WITH RESPECT TO THE PARAMETERS ASSESSED AT THE END OF WEEK 10. CONCLUSION: YOGA WAS AN EFFECTIVE AND SAFE EXERCISE FOR ALLEVIATING SHOULDER AND ARM PAIN, WHICH IS A COMPLICATION WITH A HIGH PREVALENCE IN PATIENTS WITH BREAST CANCER. 2018 5 2096 48 THE EFFECT OF YOGA EXERCISE ON IMPROVING DEPRESSION, ANXIETY, AND FATIGUE IN WOMEN WITH BREAST CANCER: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DEPRESSION, ANXIETY, AND FATIGUE ARE AMONG THE MOST SIGNIFICANT PROBLEMS THAT INFLUENCE THE QUALITY OF LIFE OF PATIENTS WITH BREAST CANCER WHO RECEIVE ADJUVANT CHEMOTHERAPY. ALTHOUGH EVIDENCE HAS SHOWN YOGA TO DECREASE ANXIETY, DEPRESSION, AND FATIGUE IN PATIENTS WITH CANCER, FEW STUDIES ON THE EFFECTS OF YOGA HAVE TARGETED PATIENTS WITH BREAST CANCER. YOGA INTERVENTIONS SHOULD BE TESTED TO PROMOTE THE PSYCHOLOGICAL AND PHYSICAL HEALTH OF WOMEN WITH BREAST CANCER. PURPOSE: THIS STUDY EXAMINES THE EFFECTIVENESS OF AN 8-WEEK YOGA EXERCISE PROGRAM IN PROMOTING THE PSYCHOLOGICAL AND PHYSICAL HEALTH OF WOMEN WITH BREAST CANCER UNDERGOING ADJUVANT CHEMOTHERAPY IN TERMS OF DEPRESSION, ANXIETY, AND FATIGUE. METHODS: A SAMPLE OF 60 WOMEN WITH NONMETASTATIC BREAST CANCER WAS RECRUITED. PARTICIPANTS WERE RANDOMLY ASSIGNED INTO EITHER THE EXPERIMENTAL GROUP (N = 30) OR THE CONTROL GROUP (N = 30). A 60-MINUTE, TWICE-PER-WEEK YOGA EXERCISE WAS IMPLEMENTED FOR 8 WEEKS AS THE INTERVENTION FOR THE PARTICIPANTS IN THE EXPERIMENTAL GROUP. THE CONTROL GROUP RECEIVED STANDARD CARE ONLY. RESULTS: ANALYSIS USING THE JOHNSON-NEYMAN PROCEDURE FOUND THAT THE YOGA EXERCISE REDUCED OVERALL FATIGUE AND THE INTERFERENCE OF FATIGUE IN EVERYDAY LIFE FOR THE EXPERIMENTAL GROUP PARTICIPANTS. SIGNIFICANT REDUCTIONS WERE OBTAINED AFTER 4 WEEKS OF INTERVENTION PARTICIPATION FOR THOSE EXPERIMENTAL GROUP PATIENTS WITH RELATIVELY LOW STARTING BASELINE VALUES (BASELINE ITEM MEAN VALUE < 3.31 AND 3.22, RESPECTIVELY) AND AFTER 8 WEEKS FOR MOST PATIENTS (APPROXIMATELY 75%) WITH MODERATE STARTING BASELINE VALUES (BASELINE ITEM MEAN VALUE < 7.30 AND 5.34, RESPECTIVELY). THE 8-WEEK INTERVENTION DID NOT SIGNIFICANTLY IMPROVE THE LEVELS OF DEPRESSION (F = 1.29, P > .05) OR ANXIETY (F = 2.7, P > .05). CONCLUSIONS/IMPLICATIONS FOR PRACTICE: THE 8-WEEK YOGA EXERCISE PROGRAM DEVELOPED IN THIS STUDY EFFECTIVELY REDUCED FATIGUE IN PATIENTS WITH BREAST CANCER BUT DID NOT REDUCE DEPRESSION OR ANXIETY. ONCOLOGY NURSES SHOULD STRENGTHEN THEIR CLINICAL HEALTH EDUCATION AND APPLY YOGA TO REDUCE THE FATIGUE EXPERIENCED BY PATIENTS WITH BREAST CANCER WHO UNDERGO ADJUVANT CHEMOTHERAPY. 2014 6 877 37 EFFECT OF YOGA THERAPY ON SYMPTOMS OF ANXIETY IN CANCER PATIENTS. BACKGROUND: MANY CANCER PATIENTS SUFFER FROM SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE. SUPPORTIVE TREATMENTS ARE INCREASINGLY USED TO ALLEVIATE DISTRESS IN CANCER. IN THIS STUDY, THE EFFECTS OF YOGA ON THESE SYMPTOMS ARE EXAMINED. METHODS: WE PERFORMED A RANDOMIZED CONTROLLED STUDY ON CANCER PATIENTS WITH MIXED DIAGNOSES COMPARING YOGA THERAPY WITH A WAITING LIST CONTROL GROUP. WE MEASURED ANXIETY SYMPTOMS WITH THE GENERAL ANXIETY DISORDER (GAD-7) SCALE, DEPRESSIVE SYMPTOMS WITH THE PATIENT HEALTH QUESTIONNAIRE-2 (PHQ-2), AND FATIGUE WITH THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER FATIGUE SCALE (EORTC QLQ-FA13). YOGA THERAPY WAS CARRIED OUT IN WEEKLY SESSIONS OF 60 MIN EACH FOR 8 WEEKS. THE PROGRAM PROVIDED RESTRAINED BODY AND BREATHING EXERCISES AS WELL AS MEDITATION. THE CONTROL GROUP DID NOT RECEIVE ANY YOGA THERAPY WHILE ON THE WAITING LIST. RESULTS: A TOTAL OF 70 SUBJECTS PARTICIPATED IN THE STUDY. ANXIETY WAS SIGNIFICANTLY REDUCED BY THE YOGA THERAPY IN THE INTERVENTION GROUP COMPARED TO THE CONTROL GROUP (P = 0.005). HOWEVER, YOGA THERAPY DID NOT SHOW ANY SIGNIFICANT EFFECTS ON DEPRESSION (P = 0.21) AND FATIGUE (P = 0.11) COMPARED TO THE CONTROL GROUP. CONCLUSION: YOGA THERAPY MAY BE USED TO ALLEVIATE ANXIETY SYMPTOMS IN CANCER PATIENTS AND SHOULD BE THE SUBJECT OF FURTHER RESEARCH. 2018 7 2080 35 THE EFFECT OF GROUP MINDFULNESS - BASED STRESS REDUCTION PROGRAM AND CONSCIOUS YOGA ON THE FATIGUE SEVERITY AND GLOBAL AND SPECIFIC LIFE QUALITY IN WOMEN WITH BREAST CANCER. BACKGROUND: CANCER IS NOT MERELY AN EVENT WITH A CERTAIN END, BUT IT IS A PERMANENT AND VAGUE SITUATION THAT IS DETERMINED BY DELAYED EFFECTS DUE TO THE DISEASE, ITS TREATMENT AND ITS RELATED PSYCHOLOGICAL ISSUES. THE AIM OF THIS STUDY WAS TO EXAMINE THE EFFECTIVENESS OF THE MINDFULNESS-BASED STRESS REDUCTION PROGRAM AND CONSCIOUS YOGA ON THE MENTAL FATIGUE SEVERITY AND LIFE QUALITY OF WOMEN WITH BREAST CANCER. METHODS: THIS WAS A QUASI-EXPERIMENTAL STUDY WITH A PRE-TEST, POST-TEST AND CONTROL GROUP. IN THIS STUDY, 24 PATIENTS WITH THE DIAGNOSIS OF BREAST CANCER WERE SELECTED AMONG THE PATIENTS WHO REFERRED TO THE DIVISION OF ONCOLOGY AND RADIOTHERAPY OF IMAM HOSSEIN HOSPITAL IN TEHRAN USING AVAILABLE SAMPLING METHOD, AND WERE RANDOMLY ASSIGNED INTO THE EXPERIMENTAL AND CONTROL GROUPS. ALL THE PARTICIPANTS COMPLETED THE FATIGUE SEVERITY SCALE, GLOBAL LIFE QUALITY OF CANCER PATIENT AND SPECIFIC LIFE QUALITY OF CANCER PATIENT QUESTIONNAIRES. DATA WERE ANALYZED BY MULTIVARIATE REPEATED MEASUREMENT VARIANCE ANALYSIS MODEL. RESULTS: FINDINGS REVEALED THAT THE MINDFULNESS-BASED STRESS REDUCTION TREATMENT SIGNIFICANTLY IMPROVED THE OVERALL QUALITY OF LIFE, ROLE, COGNITIVE, EMOTION, SOCIAL FUNCTIONS AND PAIN AND FATIGUE SYMPTOMS IN GLOBAL LIFE QUALITY IN THE EXPERIMENTAL GROUP. IT ALSO SIGNIFICANTLY IMPROVED THE BODY IMAGE, FUTURE FUNCTIONS AND THERAPY SIDE EFFECTS IN SPECIFIC LIFE QUALITY OF THE EXPERIMENTAL GROUP COMPARED TO THE CONTROL GROUP. IN ADDITION, FATIGUE SEVERITY CAUSED BY CANCER WAS REDUCED SIGNIFICANTLY. CONCLUSION: THE RESULTS SHOWED THAT THE MINDFULNESS - BASED STRESS REDUCTION TREATMENT CAN BE EFFECTIVE IN IMPROVING GLOBAL AND SPECIFIC LIFE QUALITY AND FATIGUE SEVERITY IN WOMEN WITH BREAST CANCER. 2015 8 2754 43 YOGA PRACTICE PREDICTS IMPROVEMENTS IN DAY-TO-DAY PAIN IN WOMEN WITH METASTATIC BREAST CANCER. CONTEXT: WOMEN WITH METASTATIC BREAST CANCER (MBC) EXPERIENCE A SIGNIFICANT SYMPTOM BURDEN, INCLUDING CANCER PAIN. YOGA IS A MIND-BODY DISCIPLINE THAT HAS SHOWN PROMISE FOR ALLEVIATING CANCER PAIN, BUT FEW STUDIES HAVE INCLUDED PATIENTS WITH METASTATIC DISEASE OR EXAMINED THE ACUTE EFFECTS OF YOGA PRACTICE. OBJECTIVES: TO DETERMINE WHETHER DAILY PAIN CHANGED SIGNIFICANTLY DURING A RANDOMIZED CONTROLLED TRIAL OF THE MINDFUL YOGA PROGRAM AMONG WOMEN WITH MBC AND WHETHER TIME SPENT IN YOGA PRACTICE WAS RELATED TO DAILY PAIN. METHODS: ON ALTERNATE WEEKS DURING THE INTERVENTION PERIOD, WE COLLECTED DAILY MEASURES OF PAIN FROM A SUBSET OF 48 WOMEN RANDOMIZED TO EITHER YOGA (N = 30) OR A SUPPORT GROUP CONDITION (N = 18). WE ALSO ASSESSED DAILY DURATION OF YOGA PRACTICE AMONG PATIENTS RANDOMIZED TO YOGA. RESULTS: PAIN LEVELS WERE LOW FOR WOMEN IN BOTH CONDITIONS, AND NO DIFFERENTIAL TREATMENT EFFECTS WERE FOUND ON DAILY PAIN. HOWEVER, AMONG WOMEN RANDOMIZED TO YOGA, A DOSE/RESPONSE RELATIONSHIP WAS FOUND BETWEEN YOGA PRACTICE DURATION AND DAILY PAIN. WHEN PATIENTS HAD SPENT RELATIVELY MORE TIME PRACTICING YOGA ACROSS TWO CONSECUTIVE DAYS, THEY WERE MORE LIKELY TO EXPERIENCE LOWER PAIN ON THE NEXT DAY. THIS FINDING IS CONSISTENT WITH AN EARLIER MBC STUDY. MEDITATION PRACTICE SHOWED THE STRONGEST ASSOCIATION WITH LOWER DAILY PAIN. CONCLUSION: FINDINGS SUGGEST THAT YOGA PRACTICE (MEDITATION PRACTICE IN PARTICULAR) IS ASSOCIATED WITH ACUTE IMPROVEMENTS IN CANCER PAIN, AND THAT YOGA INTERVENTIONS MAY BE MORE IMPACTFUL IF TESTED IN A SAMPLE OF PATIENTS WITH ADVANCED CANCER IN WHICH PAIN IS RELATIVELY ELEVATED. 2021 9 2605 35 YOGA FOR PERSISTENT FATIGUE IN BREAST CANCER SURVIVORS: RESULTS OF A PILOT STUDY. APPROXIMATELY ONE-THIRD OF BREAST CANCER SURVIVORS EXPERIENCES PERSISTENT FATIGUE FOR MONTHS OR YEARS AFTER SUCCESSFUL TREATMENT COMPLETION. THERE IS A LACK OF EVIDENCE-BASED TREATMENTS FOR CANCER-RELATED FATIGUE, PARTICULARLY AMONG CANCER SURVIVORS. THIS SINGLE-ARM PILOT STUDY EVALUATED THE FEASIBILITY AND PRELIMINARY EFFICACY OF A YOGA INTERVENTION FOR FATIGUED BREAST CANCER SURVIVORS BASED ON THE IYENGAR TRADITION. IYENGAR YOGA PRESCRIBES SPECIFIC POSES FOR INDIVIDUALS WITH SPECIFIC MEDICAL PROBLEMS AND CONDITIONS; THIS TRIAL EMPHASIZED POSTURES BELIEVED TO BE EFFECTIVE FOR REDUCING FATIGUE AMONG BREAST CANCER SURVIVORS, INCLUDING INVERSIONS AND BACKBENDS PERFORMED WITH THE SUPPORT OF PROPS. TWELVE WOMEN WERE ENROLLED IN THE TRIAL, AND 11 COMPLETED THE FULL 12-WEEK COURSE OF TREATMENT. THERE WAS A SIGNIFICANT IMPROVEMENT IN FATIGUE SCORES FROM PRE- TO POST-INTERVENTION THAT WAS MAINTAINED AT THE 3-MONTH POST-INTERVENTION FOLLOWUP. SIGNIFICANT IMPROVEMENTS WERE ALSO OBSERVED IN MEASURES OF PHYSICAL FUNCTION, DEPRESSED MOOD, AND QUALITY OF LIFE. THESE RESULTS SUPPORT THE ACCEPTABILITY OF THIS INTERVENTION AND SUGGEST THAT IT MAY HAVE BENEFICIAL EFFECTS ON PERSISTENT POST-TREATMENT FATIGUE. HOWEVER, RESULTS REQUIRE REPLICATION IN A LARGER RANDOMIZED CONTROLLED TRIAL. 2011 10 1564 44 LONGITUDINAL IMPACT OF YOGA ON CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT AND QUALITY OF LIFE IN WOMEN WITH EARLY STAGE BREAST CANCER: A CASE SERIES. PURPOSE: ADJUVANT CHEMOTHERAPY FOR WOMEN WITH BREAST CANCER HAS SIGNIFICANTLY IMPROVED THE CURE RATE; HOWEVER, IT HAS BEEN ASSOCIATED WITH CHEMOTHERAPY-RELATED COGNITIVE IMPACT (CRCI). THE LITERATURE PROVIDES PRELIMINARY SUPPORT FOR THE FEASIBILITY AND EFFICACY OF YOGA INTERVENTIONS FOR THE GENERAL CANCER POPULATION, HOWEVER, CONTROLLED TRIALS ARE SCARCE AND NO STUDIES HAVE EXAMINED THE EFFECT OF YOGA ON COGNITION FOR WOMEN WITH BREAST CANCER DURING CHEMOTHERAPY. THIS CASE SERIES AIMS TO IDENTIFY THE IMPACT OF YOGA ON MEASURES OF COGNITION, FUNCTIONAL OUTCOMES, AND QUALITY OF LIFE (QOL) FOR BREAST CANCER SURVIVORS (BCS). METHODS: FOUR WOMEN WITH A DIAGNOSIS OF EARLY-STAGE BREAST CANCER PRIOR TO CHEMOTHERAPY TREATMENT WERE ADMINISTERED THE FOLLOWING PHYSIOLOGIC MEASURES AT BASELINE, 6, AND 12 WEEKS DURING CHEMOTHERAPY, AND AT ONE AND THREE MONTHS AFTER THE CONCLUSION OF THE STUDY: FUNCTIONAL REACH TEST (BALANCE) AND SIT AND REACH TEST (FLEXIBILITY), AND QOL, POMS (MOOD) AND FACT-B (QOL), AT BASELINE. PRIMARY OUTCOMES OF COGNITION WERE MEASURED WITH THE PERCEIVED COGNITION QUESTIONNAIRE (PCQ) AND COGSTATE, A COMPUTERIZED MEASUREMENT OF COGNITION. WOMEN ATTENDED AN IYENGAR-INSPIRED YOGA PROGRAM TWICE A WEEK FOR 12 WEEKS. QUALITATIVE QUESTIONNAIRES WERE ADMINISTERED AFTER THE COMPLETION OF THE STUDY TO DETERMINE PERCEIVED BENEFITS AND CHALLENGES OF THE YOGA PROGRAM. RESULTS: FOUR WOMEN WITH STAGE II BREAST CANCER RANGED IN AGE FROM 44-65 YEARS. COGSTATE COMPUTERIZED TESTING SHOWED CHANGES IN VARYING DOMAINS OF COGNITION THROUGH TREATMENT AND FOLLOW-UP. IMPROVED BALANCE, FLEXIBILITY, AND QOL WERE ALSO NOTED OVER TIME. NO ADVERSE EVENTS WERE OBSERVED. ANALYSIS OF QUALITATIVE DATA REVEALED THE YOGA CLASSES WERE HELPFUL AND SUBJECTS CONTINUED THE PRACTICE ELEMENTS OF YOGA INCLUDING RELAXATION, BREATHING, AND STRETCHING. THE MOST CHALLENGING ASPECT OF THE STUDY WAS PHYSICAL LIMITATIONS DUE TO VARIOUS MEDICAL COMPLICATIONS AND INCLUDED FATIGUE, DECREASED RANGE OF MOTION, AND PAIN. CONCLUSION: THIS CASE SERIES SUGGESTS THAT YOGA MAY IMPACT VARIOUS ASPECTS OF COGNITION DURING AND AFTER CHEMOTHERAPY ADMINISTRATION AS NOTED THROUGH QUANTITATIVE MEASURES. WOMEN DESCRIBE YOGA AS IMPROVING VARIOUS DOMAINS OF QOL THROUGH THE TREATMENT TRAJECTORY. THIS MIND-BODY INTERVENTION MAY STAVE OFF CRCI; HOWEVER, FURTHER INVESTIGATION IS NEEDED FOR ADDITIONAL RANDOMIZED CONTROLLED TRIALS ON THE EFFECTS OF YOGA ON COGNITION FOR WOMEN WITH BREAST CANCER UNDERGOING ADJUVANT CHEMOTHERAPY TREATMENT. 2012 11 2235 25 THE IMPACT OF YOGA UPON FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE QUALITY OF LIFE OF FEMALE HYPOTHYROID PATIENTS. DESIGN: THE WHO QUALITY OF LIFE SCALE(22) WAS USED TO ASSESS THE QUALITY OF LIFE OF 20 FEMALE HYPOTHYROID PATIENTS. SUBJECTS ATTENDED ONE HOUR YOGA SESSIONS DAILY FOR A PERIOD OF ONE MONTH. A PRETEST-POST-TEST RESEARCH DESIGN WAS USED FOR DATA ANALYSIS. RESULTS: PATIENTS' QUALITY OF LIFE SCORES FOLLOWING THE YOGA PROGRAM WERE GREATER THAN SCORES OBTAINED PRIOR TO UNDERTAKING YOGA (P < 0.01). PATIENTS ALSO REPORTED SIGNIFICANT IMPROVEMENT IN THEIR PERCEPTION OF THE OVERALL QUALITY OF LIFE AND OF THEIR HEALTH POST YOGA INTERVENTION. CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA IS VALUABLE IN HELPING THE HYPOTHYROID PATIENTS TO MANAGE THEIR DISEASE-RELATED SYMPTOMS. YOGA MAY BE CONSIDERED AS SUPPORTIVE OR COMPLEMENTARY THERAPY IN CONJUNCTION WITH MEDICAL THERAPY FOR THE TREATMENT OF HYPOTHYROID DISORDER. 2011 12 2230 35 THE IMPACT OF YOGA ON FATIGUE IN CANCER SURVIVORSHIP: A META-ANALYSIS. BACKGROUND: MIND-BODY APPROACHES, PARTICULARLY YOGA, ARE USED BY CANCER SURVIVORS TO COPE WITH TREATMENT-RELATED SYMPTOMS. CONSISTENCY OF YOGA-RELATED EFFECTS ON TREATMENT-RELATED SYMPTOMS ARE NOT KNOWN. THIS META-ANALYSIS WAS DESIGNED TO EXAMINE EFFECTS OF YOGA ON PRE- TO POSTINTERVENTION IMPROVEMENTS IN FATIGUE AMONG CANCER PATIENTS. METHODS: PUBMED AND PSYCINFO WERE SEARCHED FOR PEER-REVIEWED ARTICLES OF YOGA RANDOMIZED CONTROLLED TRIALS INCLUDING CANCER SURVIVORS AND REPORTING AT LEAST ONE FATIGUE MEASURE. TWENTY-NINE STUDIES MET INCLUSION CRITERIA (N = 1828 PATIENTS). EFFECT SIZES (HEDGE'S G) WERE CALCULATED FOR FATIGUE, DEPRESSION, AND QUALITY OF LIFE. PATIENT-RELATED AND INTERVENTION-RELATED CHARACTERISTICS WERE TESTED AS MODERATORS OF OUTCOMES. ALL STATISTICAL TESTS WERE TWO-SIDED. RESULTS: YOGA PRACTICE WAS ASSOCIATED WITH A SMALL, STATISTICALLY SIGNIFICANT DECREASE IN FATIGUE (G = 0.45, P = .013). YOGA TYPE WAS A STATISTICALLY SIGNIFICANT MODERATOR OF THIS RELATIONSHIP (P = .02). YOGA WAS ASSOCIATED WITH A MODERATE DECREASE IN DEPRESSION (G = 0.72, P = .007) BUT WAS NOT ASSOCIATED WITH STATISTICALLY SIGNIFICANT CHANGES IN QUALITY OF LIFE (P = .48). SESSION LENGTH WAS A STATISTICALLY SIGNIFICANT MODERATOR OF THE RELATIONSHIP BETWEEN YOGA AND DEPRESSION (P = .004). NEITHER TIMING OF TREATMENT (DURING TREATMENT VS POSTTREATMENT) NOR CLINICAL CHARACTERISTICS WERE STATISTICALLY SIGNIFICANT MODERATORS OF THE EFFECTS OF YOGA ON OUTCOMES. THE EFFECT OF YOGA ON FATIGUE AND DEPRESSION WAS LARGER WHEN THE COMPARATOR WAS A "WAITLIST" OR "USUAL CARE" THAN WHEN THE CONTROL GROUP WAS ANOTHER ACTIVE TREATMENT (P = .036). CONCLUSIONS: RESULTS SUGGEST YOGA MAY BE BENEFICIAL AS A COMPONENT OF TREATMENT FOR BOTH FATIGUE AND DEPRESSION IN CANCER SURVIVORS. 2020 13 115 29 A PILOT STUDY OF A YOGA INTERVENTION FOR THE TREATMENT OF ANXIETY IN YOUNG PEOPLE WITH EARLY PSYCHOSIS. BACKGROUND: ANXIETY IS COMMON IN YOUNG PEOPLE WITH EARLY PSYCHOSIS AND TREATMENT OPTIONS FOR THIS CO-MORBIDITY REMAIN LIMITED. YOGA IS A PROMISING ADJUNCT INTERVENTION THAT HAS BEEN SHOWN TO REDUCE ANXIETY FOR ADULTS WITH SCHIZOPHRENIA, THEREFORE THIS PILOT STUDY EVALUATED THE ACCEPTABILITY AND POTENTIAL EFFECTIVENESS OF YOGA FOR ANXIETY IN EARLY PSYCHOSIS. METHODS: A PROSPECTIVE SINGLE ARM PILOT STUDY OF A YOGA INTERVENTION WAS CONDUCTED WITHIN AN EARLY INTERVENTION FOR PSYCHOSIS SERVICE. RATES OF ATTENDANCE, AS WELL AS SYMPTOMS OF ANXIETY PRE AND POST YOGA SESSION WERE MEASURED. RESULTS: A TOTAL OF 14 YOUNG PEOPLE PARTICIPATED IN THE STUDY AND OVER 70% ATTENDED HALF OR MORE OF THE YOGA SESSIONS OFFERED. SIGNIFICANT TRANSIENT REDUCTION IN STATE ANXIETY AFTER A SINGLE SESSION OF YOGA WAS OBSERVED (P < 0.01). CONCLUSIONS: YOGA WAS FOUND TO BE AN ACCEPTABLE AND POTENTIALLY EFFECTIVE ADJUNCTIVE TREATMENT FOR ANXIETY IN EARLY PSYCHOSIS AND THE RESULTS WARRANT FURTHER CLINICAL TRIALS. 2022 14 929 37 EFFECTIVENESS OF YOGA ON QUALITY OF LIFE OF BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A RANDOMIZED CLINICAL CONTROLLED STUDY. BACKGROUND: CANCER OF BREAST IS MOST COMMON CANCER AMONG WOMEN IN INDIA AND VAST MAJORITY OF COUNTRIES WORLDWIDE. WHILE UNDERGOING CHEMOTHERAPY FOR CARCINOMA MANAGEMENT, WOMEN ENCOUNTER SIDE EFFECTS, WHICH AFFECTS THEIR QUALITY OF LIFE (QOL). A RANDOMIZED CONTROLLED STUDY WITH QUANTITATIVE RESEARCH APPROACH AND TIME SERIES DESIGN WAS CONDUCTED, TO STUDY THE EFFECTIVENESS OF YOGA ON QOL OF BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY. METHODOLOGY: ONE HUNDRED BREAST CANCER PATIENTS SCHEDULED FOR 3-WEEKLY, DAY-CARE ADJUVANT CHEMOTHERAPY (CEF REGIMEN) WERE ENROLLED WITH CONSECUTIVE SAMPLING TECHNIQUE, INTO CONTROL (N = 52) AND EXPERIMENT (N = 48) GROUPS, BY CONCEALED RANDOMIZATION FOLLOWING WRITTEN INFORMED CONSENT. BASELINE DATA ON QOL WERE COLLECTED BEFORE FIRST-CYCLE CHEMOTHERAPY USING THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QLQ C30. PATIENTS IN THE EXPERIMENTAL GROUP WERE TAUGHT DIAPHRAGMATIC BREATHING TECHNIQUES, SYSTEMATIC RELAXATION, AND ALTERNATE NOSTRIL BREATHING, AND JOINTS AND GLANDS NECK AND SHOULDER EXERCISES WERE INSTRUCTED TO PRACTICE TWICE DAILY AT HOME. THEY WERE SUPERVISED IN PRACTICING THESE TECHNIQUES WHILE THEY RECEIVED SECOND, THIRD, FOURTH, FIFTH, AND SIXTH CYCLES OF CHEMOTHERAPY IN THE DAY-CARE FACILITY. PARTICIPANTS IN THE CONTROL GROUP RECEIVED ONLY ROUTINE CARE. ALL PARTICIPANTS RECEIVED STANDARD POST CHEMOTHERAPY PRESCRIPTION. DATA ON QOL WERE COLLECTED FROM ALL PATIENTS DURING THE SECOND, THIRD, FOURTH, FIFTH, AND SIXTH CYCLES OF CHEMOTHERAPY. RESULTS: THE ANALYSIS REVEALED THAT AT THE BASELINE (FIRST CHEMOTHERAPY CYCLE), BREAST CANCER PATIENTS IN CONTROL AND EXPERIMENTAL GROUPS WERE HOMOGENEOUS IN TERMS OF THEIR SOCIODEMOGRAPHIC AND CLINICAL VARIABLES AND QOL SCORE. YOGA PRACTICES WERE EFFECTIVE IN IMPROVING THE QOL OF BREAST CANCER PATIENTS IN THE EXPERIMENTAL GROUP IN THE AREAS OF GLOBAL HEALTH STATUS, PHYSICAL FUNCTION, ROLE FUNCTION, AND EMOTIONAL FUNCTION AND DECREASING THE SYMPTOMS OF FATIGUE, INSOMNIA, LOSS OF APPETITE, AND CONSTIPATION, DURING THE PERIOD OF CHEMOTHERAPY. CONCLUSION: YOGA PRACTICES COMPRISING OF RELAXATION TECHNIQUES REDUCE MANY SIDE EFFECTS AND IMPROVE THE QOL OF WOMEN UNDERGOING CHEMOTHERAPY FOR BREAST CANCER. 2020 15 1240 40 FEASIBILITY OF A MINDFUL YOGA PROGRAM FOR WOMEN WITH METASTATIC BREAST CANCER: RESULTS OF A RANDOMIZED PILOT STUDY. PURPOSE: PATIENTS WITH METASTATIC BREAST CANCER (MBC) EXPERIENCE HIGH LEVELS OF SYMPTOMS. YOGA INTERVENTIONS HAVE SHOWN PROMISE FOR IMPROVING CANCER SYMPTOMS BUT HAVE RARELY BEEN TESTED IN PATIENTS WITH ADVANCED DISEASE. THIS STUDY EXAMINED THE ACCEPTABILITY OF A COMPREHENSIVE YOGA PROGRAM FOR MBC AND THE FEASIBILITY OF CONDUCTING A RANDOMIZED TRIAL TESTING THE INTERVENTION. METHODS: SIXTY-THREE WOMEN WITH MBC WERE RANDOMIZED WITH A 2:1 ALLOCATION TO YOGA OR A SUPPORT GROUP COMPARISON CONDITION. BOTH INTERVENTIONS INVOLVED EIGHT WEEKLY GROUP SESSIONS. FEASIBILITY WAS QUANTIFIED USING RATES OF ACCRUAL, ATTRITION, AND SESSION ATTENDANCE. ACCEPTABILITY WAS ASSESSED WITH A STANDARDIZED SELF-REPORT MEASURE. PAIN, FATIGUE, SLEEP QUALITY, PSYCHOLOGICAL DISTRESS, MINDFULNESS, AND FUNCTIONAL CAPACITY WERE ASSESSED AT BASELINE, POST-INTERVENTION, AND 3 AND 6 MONTHS POST-INTERVENTION. RESULTS: WE MET GOALS FOR ACCRUAL AND RETENTION, WITH 50% OF ELIGIBLE PATIENTS ENROLLED AND 87% OF RANDOMIZED PARTICIPANTS COMPLETING POST-INTERVENTION SURVEYS. SIXTY-FIVE PERCENT OF WOMEN IN THE YOGA CONDITION AND 90% IN THE SUPPORT GROUP ATTENDED >/= 4 SESSIONS. EIGHTY PERCENT OF PARTICIPANTS IN THE YOGA CONDITION AND 65% IN THE SUPPORT GROUP INDICATED THAT THEY WERE HIGHLY SATISFIED WITH THE INTERVENTION. FOLLOWING TREATMENT, WOMEN IN THE YOGA INTERVENTION HAD MODEST IMPROVEMENTS IN SOME OUTCOMES; HOWEVER, OVERALL SYMPTOM LEVELS WERE LOW FOR WOMEN IN BOTH CONDITIONS. CONCLUSIONS: FINDINGS SUGGEST THAT THE YOGA INTERVENTION CONTENT WAS HIGHLY ACCEPTABLE TO PATIENTS WITH MBC, BUT THAT THERE ARE CHALLENGES TO IMPLEMENTING AN INTERVENTION INVOLVING EIGHT GROUP-BASED IN-PERSON SESSIONS. ALTERNATIVE MODES OF DELIVERY MAY BE NECESSARY TO REACH PATIENTS MOST IN NEED OF INTERVENTION. 2019 16 2623 34 YOGA FOR SYMPTOM MANAGEMENT IN ONCOLOGY: A REVIEW OF THE EVIDENCE BASE AND FUTURE DIRECTIONS FOR RESEARCH. BECAUSE YOGA IS INCREASINGLY RECOGNIZED AS A COMPLEMENTARY APPROACH TO CANCER SYMPTOM MANAGEMENT, PATIENTS/SURVIVORS AND PROVIDERS NEED TO UNDERSTAND ITS POTENTIAL BENEFITS AND LIMITATIONS BOTH DURING AND AFTER TREATMENT. THE AUTHORS REVIEWED RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA CONDUCTED AT THESE POINTS IN THE CANCER CONTINUUM (N = 29; N = 13 DURING TREATMENT, N = 12 POST-TREATMENT, AND N = 4 WITH MIXED SAMPLES). FINDINGS BOTH DURING AND AFTER TREATMENT DEMONSTRATED THE EFFICACY OF YOGA TO IMPROVE OVERALL QUALITY OF LIFE (QOL), WITH IMPROVEMENT IN SUBDOMAINS OF QOL VARYING ACROSS STUDIES. FATIGUE WAS THE MOST COMMONLY MEASURED OUTCOME, AND MOST RCTS CONDUCTED DURING OR AFTER CANCER TREATMENT REPORTED IMPROVEMENTS IN FATIGUE. RESULTS ALSO SUGGESTED THAT YOGA CAN IMPROVE STRESS/DISTRESS DURING TREATMENT AND POST-TREATMENT DISTURBANCES IN SLEEP AND COGNITION. SEVERAL RCTS PROVIDED EVIDENCE THAT YOGA MAY IMPROVE BIOMARKERS OF STRESS, INFLAMMATION, AND IMMUNE FUNCTION. OUTCOMES WITH LIMITED OR MIXED FINDINGS (EG, ANXIETY, DEPRESSION, PAIN, CANCER-SPECIFIC SYMPTOMS, SUCH AS LYMPHEDEMA) AND POSITIVE PSYCHOLOGICAL OUTCOMES (SUCH AS BENEFIT-FINDING AND LIFE SATISFACTION) WARRANT FURTHER STUDY. IMPORTANT FUTURE DIRECTIONS FOR YOGA RESEARCH IN ONCOLOGY INCLUDE: ENROLLING PARTICIPANTS WITH CANCER TYPES OTHER THAN BREAST, STANDARDIZING SELF-REPORT ASSESSMENTS, INCREASING THE USE OF ACTIVE CONTROL GROUPS AND OBJECTIVE MEASURES, AND ADDRESSING THE HETEROGENEITY OF YOGA INTERVENTIONS, WHICH VARY IN TYPE, KEY COMPONENTS (MOVEMENT, MEDITATION, BREATHING), DOSE, AND DELIVERY MODE. 2019 17 2442 38 YOGA AND SELF-REPORTED COGNITIVE PROBLEMS IN BREAST CANCER SURVIVORS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: CANCER SURVIVORS OFTEN REPORT COGNITIVE PROBLEMS. FURTHERMORE, DECREASES IN PHYSICAL ACTIVITY TYPICALLY OCCUR OVER THE COURSE OF CANCER TREATMENT. ALTHOUGH PHYSICAL ACTIVITY BENEFITS COGNITIVE FUNCTION IN NONCANCER POPULATIONS, EVIDENCE LINKING PHYSICAL ACTIVITY TO COGNITIVE FUNCTION IN CANCER SURVIVORS IS LIMITED. IN OUR RECENT RANDOMIZED CONTROLLED TRIAL, BREAST CANCER SURVIVORS WHO RECEIVED A YOGA INTERVENTION HAD LOWER FATIGUE AND INFLAMMATION FOLLOWING THE TRIAL COMPARED WITH A WAIT LIST CONTROL GROUP. THIS SECONDARY ANALYSIS OF THE PARENT TRIAL ADDRESSED YOGA'S IMPACT ON COGNITIVE COMPLAINTS. METHODS: POSTTREATMENT STAGE 0-IIIA BREAST CANCER SURVIVORS (N = 200) WERE RANDOMIZED TO A 12-WEEK, TWICE-WEEKLY HATHA YOGA INTERVENTION OR A WAIT LIST CONTROL GROUP. PARTICIPANTS REPORTED COGNITIVE COMPLAINTS USING THE BREAST CANCER PREVENTION TRIAL COGNITIVE PROBLEMS SCALE AT BASELINE, IMMEDIATELY POSTINTERVENTION, AND 3-MONTH FOLLOW-UP. RESULTS: COGNITIVE COMPLAINTS DID NOT DIFFER SIGNIFICANTLY BETWEEN GROUPS IMMEDIATELY POSTINTERVENTION (P = 0.250). HOWEVER, AT 3-MONTH FOLLOW-UP, YOGA PARTICIPANTS' BREAST CANCER PREVENTION TRIAL COGNITIVE PROBLEMS SCALE SCORES WERE AN AVERAGE OF 23% LOWER THAN WAIT LIST PARTICIPANTS' SCORES (P = 0.003). THESE GROUP DIFFERENCES IN COGNITIVE COMPLAINTS REMAINED AFTER CONTROLLING FOR PSYCHOLOGICAL DISTRESS, FATIGUE, AND SLEEP QUALITY. CONSISTENT WITH THE PRIMARY RESULTS, THOSE WHO PRACTICED YOGA MORE FREQUENTLY REPORTED SIGNIFICANTLY FEWER COGNITIVE PROBLEMS AT 3-MONTH FOLLOW-UP THAN THOSE WHO PRACTICED LESS FREQUENTLY (P < 0.001). CONCLUSIONS: THESE FINDINGS SUGGEST THAT YOGA CAN EFFECTIVELY REDUCE BREAST CANCER SURVIVORS' COGNITIVE COMPLAINTS AND PROMPT FURTHER RESEARCH ON MIND-BODY AND PHYSICAL ACTIVITY INTERVENTIONS FOR IMPROVING CANCER-RELATED COGNITIVE PROBLEMS. 2015 18 2877 35 YOGA-SPECIFIC ENHANCEMENT OF QUALITY OF LIFE AMONG WOMEN WITH BREAST CANCER: SYSTEMATIC REVIEW AND EXPLORATORY META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. PHYSICAL ACTIVITIES DURING AND AFTER CANCER TREATMENT HAVE FAVORABLE PSYCHOSOCIAL EFFECTS. INCREASINGLY, YOGA HAS BECOME A POPULAR APPROACH TO IMPROVING THE QUALITY OF LIFE (QOL) OF WOMEN WITH BREAST CANCER. HOWEVER, THE EXTANT SYNTHETIC EVIDENCE ON YOGA HAS NOT USED OTHER EXERCISE COMPARISON CONDITIONS. THIS META-ANALYSIS AIMED TO SYSTEMATICALLY ASSESS YOGA-SPECIFIC EFFECTS RELATIVE TO ANY OTHER PHYSICAL EXERCISE INTERVENTION (EG, AEROBICS) FOR WOMEN WITH BREAST CANCER. QOL WAS THE PRIMARY OUTCOME OF INTEREST. EIGHT RANDOMIZED CONTROLLED TRIALS WITH 545 PARTICIPANTS WERE INCLUDED. THE SAMPLE-WEIGHTED SYNTHESIS AT IMMEDIATE POSTINTERVENTION REVEALED MARGINALLY STATISTICALLY AND MODEST PRACTICALLY SIGNIFICANT DIFFERENCES SUGGESTING YOGA'S POTENTIALLY GREATER EFFECTIVENESS: D = 0.14, P = .10. HOWEVER, AT LONGER TERM FOLLOW-UP, NO STATISTICALLY OR PRACTICALLY SIGNIFICANT BETWEEN-GROUP DIFFERENCE WAS OBSERVED. THIS META-ANALYSIS PRELIMINARILY DEMONSTRATED THAT YOGA IS PROBABLY AS EFFECTIVE AS OTHER EXERCISE MODALITIES IN IMPROVING THE QOL OF WOMEN WITH BREAST CANCER. BOTH INTERVENTIONS WERE ASSOCIATED WITH CLINICALLY SIGNIFICANT IMPROVEMENTS IN QOL. NEARLY ALL OF THE YOGA INTERVENTION PROGRAMS, HOWEVER, WERE VERY POORLY RESOURCED. LARGER AND BETTER CONTROLLED TRIALS OF WELL-ENDOWED YOGA PROGRAMS ARE NEEDED. 2019 19 2883 30 YOGA: A TOOL FOR IMPROVING THE QUALITY OF LIFE IN CHRONIC PANCREATITIS. AIM: TO DETERMINE THE EFFECTIVENESS OF YOGA ON IMPROVING THE QUALITY OF LIFE IN PATIENTS OF CHRONIC PANCREATITIS. METHODS: THE PATIENTS WERE RANDOMIZED TO TWO GROUPS. THE CONTROL GROUP CONTINUED THEIR USUAL CARE AS DIRECTED BY THEIR PHYSICIANS. PATIENTS IN THE YOGA GROUP, IN ADDITION, RECEIVED BIWEEKLY YOGA SESSIONS FOR 12 WK. THE PATIENTS' DEMOGRAPHIC AND HEALTH BEHAVIOUR VARIABLES WERE ASSESSED BEFORE AND AFTER THE YOGA PROGRAMME USING MEDICAL OUTCOMES SHORT FORM (SF-36) FOR QUALITY OF LIFE, PROFILE OF MOOD STATES FOR ASSESSING MOOD AND SYMPTOMS OF STRESS INVENTORY FOR MEASURING STRESS. RESULTS: A TOTAL OF 60 PATIENTS WERE ENROLLED, WITH 8 DROP-OUTS. THIRTY PATIENTS WERE RANDOMIZED TO THE YOGA GROUP AND 30 TO THE CONTROL GROUP. SIGNIFICANT IMPROVEMENTS WERE SEEN IN OVERALL QUALITY OF LIFE, SYMPTOMS OF STRESS, MOOD CHANGES, ALCOHOL DEPENDENCE AND APPETITE AFTER THE 12 WK PERIOD APART FROM THE GENERAL FEELING OF WELL-BEING AND DESIRE TO CONTINUE WITH THE PROGRAMME IN FUTURE IN THE YOGA GROUP, WHILE THERE WAS NO DIFFERENCE IN THE CONTROL GROUP. CONCLUSION: YOGA IS EFFECTIVE ON IMPROVING THE QUALITY OF LIFE IN PATIENTS OF CHRONIC PANCREATITIS. 2007 20 2609 38 YOGA FOR QUALITY OF LIFE IN INDIVIDUALS WITH CHRONIC DISEASE: A SYSTEMATIC REVIEW. BACKGROUND: CHRONIC DISEASES, INCLUDING HEART DISEASE, STROKE, CANCER, AND CHRONIC PULMONARY DISEASE ARE THE LEADING CAUSES OF DEATH AND DISABILITY WORLDWIDE. COMPOUNDING SYMPTOMS AND LOSS OF FUNCTION, PEOPLE LIVING WITH CHRONIC DISEASE OFTEN EXPERIENCE REDUCED QUALITY OF LIFE (QOL). VARIOUS PHYSICAL AND MENTAL PRACTICES HAVE BEEN SHOWN TO RELIEVE STRESS AND IMPROVE QOL. YOGA IS A PHYSICAL AND MENTAL PRACTICE THAT MAY BE A VIABLE APPROACH FOR IMPROVING QOL IN PEOPLE WITH CHRONIC DISEASE. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EXAMINE AND SUMMARIZE THE EVIDENCE FOR THE EFFECTIVENESS OF YOGA ON QOL IN PATIENTS WITH CHRONIC DISEASE. DESIGN: THE STUDY DESIGN WAS A A SYSTEMATIC REVIEW WITH QUALITATIVE SYNTHESIS. METHODS: WE INCLUDED RANDOMIZED CONTROLLED TRIALS THAT EVALUATED THE EFFECT OF YOGA ON QOL OR HEALTH-RELATED QOL (HRQOL) FOR INDIVIDUALS WITH CHRONIC DISEASE. WE INCLUDED ONLY STUDIES THAT USED AT LEAST 1 PREVIOUSLY VALIDATED MEASURE OF QOL OR HRQOL AND SPECIFIED A MINIMUM DURATION OF FOLLOW-UP OF AT LEAST 1 WK. INTERVENTIONS: WE INCLUDED BOTH MOVEMENT-BASED AND BREATH-BASED YOGA PRACTICES. STUDIES THAT INCLUDED YOGA AS PART OF A LARGER INTERVENTION PROGRAM (EG, MINDFULNESS-BASED STRESS REDUCTION TRAINING) OR STUDIES THAT DID NOT PROVIDE FINDINGS SPECIFIC TO YOGA WERE EXCLUDED. PRIMARY OUTCOME MEASURES: THE PRIMARY OUTCOME ANALYZED WAS IMPROVEMENT IN QOL AS MEASURED BY A VALIDATED QOL OR HRQOL SCALE. RESULTS: AMONG THE 1488 STUDIES THAT WERE IDENTIFIED ON INITIAL SEARCH, 7 ARTICLES MET ALL INCLUSION CRITERIA. FIVE STUDIES REPORTED A STATISTICALLY SIGNIFICANT ADVANTAGE OVER USUAL CARE ALONE FOR IMPROVEMENT OF QOL IN PATIENTS WITH CHRONIC DISEASE, BUT THE CLINICAL SIGNIFICANCE OF THE DIFFERENCES WAS CLEAR IN ONLY 1 TRIAL. WE FOUND CONSIDERABLE HETEROGENEITY AMONG THE INCLUDED STUDIES AND STUDY QUALITY WAS GENERALLY LOW. CONCLUSIONS: MORE HIGH-QUALITY RESEARCH IS NEEDED TO DETERMINE THE VALUE OF YOGA AS AN ADJUNCTIVE APPROACH TO IMPROVING QOL IN PATIENTS WITH CHRONIC DISEASE. 2019